1-异丙氧基戊烷 | 5756-37-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-异丙氧基戊烷
• 英文名称: Isopropyl-pentylaether
• 英文别名: Isopropyl pentyl ether；1-propan-2-yloxypentane
• CAS: 5756-37-6
• 化学式: C₈H₁₈O
• 分子量: 130.23
• InChiKey: FDUGUUVTGOZJQR-UHFFFAOYSA-N

物化性质

• 熔点：
  -94°C (estimate)
• 沸点：
  140.96°C (estimate)
• 密度：
  0.7809 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  戊醇 、 三氟甲磺酸异丙酯 在 二氯甲烷 、 sodium sulfate 作用下， 生成 1-异丙氧基戊烷
  参考文献：
  名称：

  Synthesis of some novel trifluoromethanesulfonates and their reactions with alcohols

  摘要：

  DOI：

  10.1021/jo00961a003

文献信息

• COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
  申请人：Lantheus Medical Imaging, Inc.

  公开号：US20150196672A1

  公开（公告）日：2015-07-16

  The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

  本发明提供了具有成像基团的化合物，用于对受试者进行成像。本发明还涉及用于合成和使用成像试剂或其前体的系统、组合物和方法。成像试剂前体可以使用本文所述的方法转化为成像试剂。在某些情况下，组合物或多种成像试剂富集于 18 F。在某些情况下，成像试剂可用于成像受试者的感兴趣区域，包括但不限于心脏、心血管系统、心脏血管、大脑和其他器官。
• Diaryl piperidines as CB1 modulators
  申请人：Scott D. Jack

  公开号：US20070203183A1

  公开（公告）日：2007-08-30

  A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome (e.g., obesity, waist circumference, lipid profile, and insulin sensitivity), neuroinflammatory disorders, cognitive disorders, psychosis, addictive behavior, gastrointestinal disorders, and cardiovascular conditions.

  具有通式（I）的一种化合物，或其药学上可接受的盐、溶剂合物或酯，可用于治疗代谢综合征（例如肥胖、腰围、脂质谱和胰岛素敏感性）、神经炎症性疾病、认知障碍、精神病、成瘾行为、胃肠道疾病和心血管疾病等疾病、疾病或症状。
• Process for producing alpha-olefin
  申请人：KURARAY CO., LTD

  公开号：US20030065233A1

  公开（公告）日：2003-04-03

  A production process for &agr;-olefins making use of elimination reaction of a primary alcohol or an ether is characterized by use of an alumina catalyst in the presence of an amine. The production process for &agr;-olefins according to the present invention can yield an &agr;-olefin at a high proportion with respect to the entire olefin products and can maintain the reactivity of the catalyst and selectivity of the products for a prolonged time. In the process, unreacted material and ether intermediate byproduct produced in the process can be used in the reaction with the same catalyst. This allows industrially and environmentally favorable production process of &agr;-olefins.

  一种生产α-烯烃的生产工艺，利用一次醇或醚的消除反应，其特征在于在胺的存在下使用氧化铝催化剂。根据本发明的α-烯烃生产工艺可以高比例地产生α-烯烃，同时可以长时间保持催化剂的反应性和产品的选择性。在该过程中，未反应的物料和过程中产生的醚中间体副产物可以与相同的催化剂一起用于反应。这使得α-烯烃的工业和环境友好的生产工艺成为可能。
• Novel quinoxalinone derivatives
  申请人：Hirai Hiroshi

  公开号：US20060019959A1

  公开（公告）日：2006-01-26

  A quinoxalinone derivative of the formula (I): or a pharmaceutically acceptable salt or ester thereof, wherein; X is NH, S or the like; Y is O or the like; the partial structure is, for example, the formula: B 1 , B 2 , . . . , B n-1 and B n , (in which n is 4, 5 or 6) are each independently CH, N or the like; B′ 1 , B′ 2 , . . . , B′ n-1 and B′ n (in which n is 4, 5 or 6) are each independently hydrogen or the like; and R is hydrogen, lower alkyl or the like.

  公式（I）的喹喔啉酮衍生物，或其药学上可接受的盐或酯，其中：X为NH，S或类似物；Y为O或类似物；部分结构为，例如，公式：B1，B2，...，Bn-1和Bn（其中n为4，5或6）分别独立地为CH，N或类似物；B'1，B'2，...，B'n-1和B'n（其中n为4，5或6）分别独立地为氢或类似物；以及R为氢，较低的烷基或类似物。
• Inhibitors of human immunodeficiency virus replication
  申请人：TSANTRIZOS Youla S.

  公开号：US20080221159A1

  公开（公告）日：2008-09-11

  Compounds of formula I: wherein a, b, c, X, R 2 , R 3 , R 4 , R 6 and R 7 are defined herein, are useful as inhibitors of HIV replication.

  式I的化合物：其中a、b、c、X、R2、R3、R4、R6和R7如此定义，对于抑制HIV复制是有用的。

表征谱图